COVID-19: Vaccination extended to short-term pass holders

Singapore’s Ministry of Health recently announced that some short-term pass holders are now eligible to receive the COVID-19 vaccine.

Key Points:

• As of Aug. 18, short-term pass holders (STPHs) who have been in Singapore for an extended period of time are eligible to receive a COVID-19 vaccine through the country’s vaccination program.
  • Individuals on Special Passes, Training Employment Passes (TEP), Training Work Permits (TWP) or Work Holiday Passes (WHP) are eligible to receive the vaccination.
  • Short-Term Visit Pass holders who have been in the country for more than 60 days continuously are eligible for the vaccination program.
• TEP, TWP, WHP and Special Pass holders do not need an appointment to receive the vaccination. Such individuals must bring their passport and applicable pass for verification purposes.
• All short-term visit pass holders with registered phone numbers will receive a text message with a link to vaccine.gov.sg to book a vaccination appointment.

Additional Information: The COVID-19 vaccine will be provided for free to all eligible STPHs, but those individuals will not receive the Vaccine Injury Financial Assistance Program. The aforementioned groups will receive their vaccination status in the TraceTogether app in September or later. As of Aug. 16, 76% of people in Singapore are fully vaccinated against COVID-19 and 82% have received at least one dose.

BAL Analysis: The Singaporean government is extending the vaccination program to short-stay groups to further protect the country against COVID-19. The response to the COVID-19 pandemic continues to develop, and BAL will provide additional updates as information becomes available.

This alert has been provided by the BAL Global Practice group. For additional information, please contact berryapplemanleiden@bal.com.

Copyright © 2021 Berry Appleman & Leiden LLP. All rights reserved. Reprinting or digital redistribution to the public is permitted only with the express written permission of Berry Appleman & Leiden LLP. For inquiries, please contact copyright@bal.com.